LMAT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,616.42 -- higher than 97.52% of US-listed equities with positive expected earnings growth.
The price/operating cash flow metric for Lemaitre Vascular Inc is higher than 85.88% of stocks in our set with a positive cash flow.
With a year-over-year growth in debt of 1,091.05%, Lemaitre Vascular Inc's debt growth rate surpasses 98.21% of about US stocks.
Stocks with similar financial metrics, market capitalization, and price volatility to Lemaitre Vascular Inc are SSTK, SSD, ATRI, PLPC, and CRTO.
LMAT's SEC filings can be seen here. And to visit Lemaitre Vascular Inc's official web site, go to www.lemaitre.com.
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The company was founded in 1983 and is based in Burlington, Massachusetts.
LMAT Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Lemaitre Vascular Inc. To summarize, we found that Lemaitre Vascular Inc ranked in the 52th percentile in terms of potential gain offered. More precisely, our analysis suggests the stock is undervalued by approximately 27% on a DCF basis. In terms of the factors that were most noteworthy in this DCF analysis for LMAT, they are:
The business' balance sheet suggests that 9% of the company's capital is sourced from debt; this is greater than merely 22.78% of the free cash flow producing stocks we're observing.
The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than only 0% of stocks in its sector (Healthcare).
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
Want more companies with a valuation profile/forecast similar to that of Lemaitre Vascular Inc? See CBPO, SNY, EGRX, AMED, and ACIU.
BURLINGTON, Mass., July 29, 2020 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in two investor conferences in August. JJ Pellegrino, Chief Financial Officer, is scheduled to present at the virtual Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020, at 8:00 AM EDT.David Roberts, President, is scheduled to participate in the virtual 5th Annual Needham Med Tech & Diagnostics 1×1 Conference on Monday, August 17, 2020.About LeMaitre VascularLeMaitre Vascular is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to ad...
LeMaitre Vascular, Inc. (LMAT) Q2 2020 Earnings Conference Call July 23, 2020 05:00 PM ET Company Participants Joseph Pellegrino - Chief Financial Officer, Treasurer and Secretary George LeMaitre - Chairman and Chief Executive Officer David Roberts - President Conference Call Participants Cecilia Furlong - Canaccord Genuity Group Inc. Andrew Ranieri...